Targeted Neoadjuvant Therapies in HR+/HER2−Breast Cancers: Challenges for Improving pCR

SIMPLE SUMMARY: A high pathological complete response in the neoadjuvant setting is directly associated with a better overall response. A favorable prognosis is achieved when preoperative chemo or endocrine therapy succeeds in achieving a high pathological complete response (total eradication of tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Dey, Nandini, Aske, Jennifer, De, Pradip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866155/
https://www.ncbi.nlm.nih.gov/pubmed/33530335
http://dx.doi.org/10.3390/cancers13030458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866155/
https://www.ncbi.nlm.nih.gov/pubmed/33530335
http://dx.doi.org/10.3390/cancers13030458

Ejemplares similares